Skip navigation
Please use this identifier to cite or link to this item: https://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/530
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSmith, S. J.-
dc.contributor.authorSmith, A. B.-
dc.contributor.authorKennett, W.-
dc.contributor.authorVinod, S. K.-
dc.date.accessioned2025-02-19T05:23:08Z-
dc.date.available2025-02-19T05:23:08Z-
dc.date.issued2022-10-
dc.identifier.citationPatient Education and Counseling. 2022 Oct;105(10):3134-3142. doi: 10.1016/j.pec.2022.06.001.en
dc.identifier.urihttps://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/530-
dc.description.abstractObjectives: The COVID-19 pandemic has significantly impacted oncology. With pandemic restrictions limiting close contact between individuals, telehealth (the use of teleconferencing/videoconferencing to conduct real-time medical consultations) has been increasingly utilised. This qualitative study aimed to explore adult cancer patient, caregiver, and clinician (doctor, nurse, allied health) telehealth experiences during COVID-19 in urban and rural Australian settings and identify potential enablers and barriers to sustained telehealth implementation. Methods: English-speaking participants completed semi-structured interviews regarding their telehealth experiences since March 2020. Interviews ceased when data saturation occurred. Iterative thematic analysis was conducted using NVivo 12 Pro. Results: Thirty-four interviews (clinician=14, patient=13, caregiver=7) were conducted from April to August 2021. Analysis generated seven themes relating to telehealth use: 1) Acceptability as a form of consultation, 2) Impacts on healthcare provision, 3) Communication & relationships, 4) Efficient form of consultation, 5) Comfort of conducting telehealth in different environments, 6) Technological barriers and 7) Future preferences. Conclusions: The rapid uptake of telehealth during the pandemic has mostly been well-received, and telehealth can be appropriately used in oncology. Practice implications: Barriers including providing appropriate facilities, technology, and telehealth training; and selecting appropriate patients must be addressed to enable sustained telehealth use in future cancer care.en
dc.language.isoenen
dc.subjectPandemicsen
dc.subjectCOVID-19en
dc.subjectTelemedicineen
dc.subjectReferral and Consultationen
dc.subjectVideoconferencingen
dc.subjectNeoplasmsen
dc.titleExploring cancer patients', caregivers', and clinicians' utilisation and experiences of telehealth services during COVID-19: A qualitative studyen
dc.typeArticleen
dc.contributor.mnclhdauthorKennett, William-
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35688719/en
dc.identifier.doi10.1016/j.pec.2022.06.001en
Appears in Collections:Oncology / Cancer

Files in This Item:
File SizeFormat  
main.pdf962.56 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing